Facebook
Twitter
LinkedIn
ForwardPULSE: Exasperation with Exacerbations: Use of Eosinophils to Guide COPD Treatment - January 13, 2021
New medication or old medications with new uses, as well as new treatment guidelines are constantly coming out. Pharmacists need to be aware of clinical controversies and stay up-to-date with the pharmacotherapy and therapeutics of all medications.
Target Audience
Pharmacists at UPMC, Pharmacy Faculty at PittPharmacy, Pharmacy Residents, Pharmacy Students
Learning Objectives
1. Define COPD and review current COPD treatment options
2. Identify eosinophils and their role as disease biomarkers
3. Discuss the current evidence for inhaled corticosteroids in eosinophilic COPD and their place in therapy
New medication or old medications with new uses, as well as new treatment guidelines are constantly coming out. Pharmacists need to be aware of clinical controversies and stay up-to-date with the pharmacotherapy and therapeutics of all medications.
Katherine Halza, PharmD
PGY2 Ambulatory Care - Family Medicine Track
UPMC Presbyterian/ Shadyside
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Available Credit
- 1.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.